New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences?

BACKGROUND The International Society of Nephrologists and Renal Pathology Society (ISN/RPS) classification of lupus nephritis proposes a controversial subclassification of class IV lupus nephritis into IV-segmental (IV-S) and IV-global (IV-G). METHODS A retrospective analysis of a biopsy-proven cohort of patients with lupus nephritis using the ISN/RPS classification was performed. RESULTS The prevalence of class IV was 47% in the cohort of 70 patients with lupus nephritis. Of 33 patients with class IV lupus nephritis, 11 patients had class IV-S and 22 patients had class IV-G. There were no significant differences in age, sex, and ethnicity in the 2 groups. Greater serological activity (lower C4 level) was observed in the IV-S group, whereas serum creatinine levels and diastolic blood pressures were significantly greater in the IV-G group. Hematocrit levels, significant proteinuria (urine protein > or =3 + ), duration of systemic lupus erythematosus, and the Systemic Lupus Erythematosus Disease Activity Index were similar in the 2 groups. Histologically, combined lesions with segmental endocapillary proliferation and fibrinoid necrosis were significantly more frequent in the IV-S group. The percentage of glomeruli with cellular crescents also was greater in the IV-S group, but the difference was not significant. Wire loops were more common in the IV-G group. Transformation to IV-G was observed in 2 of 3 specimens from repeated biopsies available in the IV-S group; greater than 50% of the IV-G group had both segmental and global glomerular involvement. No significant difference was detected in outcomes in the 2 groups after average follow-ups of 38 and 55 months in the IV-S and IV-G groups, respectively. CONCLUSION A clinical and prognostic distinction between IV-S and IV-G remains to be proven.

[1]  A. Michael,et al.  Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. , 1985, The New England journal of medicine.

[2]  J. Esdaile,et al.  Can Experienced Clinicians Predict the Outcome of Lupus Nephritis? , 1992, Lupus.

[3]  Joni K. Evans,et al.  Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. , 2001, Kidney international.

[4]  J. Churg,et al.  Focal segmental lupus nephritis. , 1982, Clinical nephrology.

[5]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[6]  R. Glassock,et al.  Renal disease : classification and atlas , 1987 .

[7]  C. Ponticelli,et al.  Long-term prognosis of diffuse lupus nephritis. , 1987, Clinical nephrology.

[8]  E. Lewis,et al.  The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. , 1987, Kidney international.

[9]  G. Appel,et al.  Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization. , 1987, The American journal of medicine.

[10]  V. D’Agati,et al.  Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. , 1994, Clinical nephrology.

[11]  D. Boumpas,et al.  High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  J. Balfe,et al.  Correlation of renal histology with outcome in children with lupus nephritis. , 1986, Kidney international.

[13]  E. Smithwick,et al.  Diffuse proliferative lupus nephritis , 1973 .

[14]  Joni K. Evans,et al.  Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  L R Muenz,et al.  Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. , 1984, Kidney international.

[16]  S Suissa,et al.  Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. , 1991, The Quarterly journal of medicine.

[17]  R. Falk,et al.  Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Glomerular Disease Collaborative Network. , 1997, Kidney international.

[18]  S. Henzen‐Logmans,et al.  Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. , 1990, Arthritis and rheumatism.

[19]  J. Esdaile,et al.  The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. , 1989, The Quarterly journal of medicine.

[20]  J. Klippel,et al.  Prognostic factors in lupus nephritis. Contribution of renal histologic data. , 1983, The American journal of medicine.

[21]  D. Alarcón-Segovia,et al.  Factors associated with chronic renal failure in 121 patients with diffuse proliferative lupus nephritis: a case-control study , 1995, Lupus.

[22]  D. Wallace,et al.  Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. , 1995, Seminars in arthritis and rheumatism.

[23]  D. Sackett,et al.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.

[24]  E. Lewis,et al.  Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative Study , 1992, Annals of Internal Medicine.